Posted by Brigham and Women's Hospital September 17, 2013
In observance of World Alzheimer’s Month, we’ve gathered recent posts about the work of our physicians who are leading research to understand and develop new treatments for Alzheimer’s disease.
Dr. Reisa Sperling believes that earlier treatment, prior to development of symptoms, is key to helping people with Alzheimer’s disease. This approach is consistent with how we’ve made progress against other diseases, such as reducing cholesterol to prevent heart disease. Learn how Dr. Sperling is applying this approach to Alzheimer’s disease.
Thanks to some intercontinental teamwork, researchers have identified a gene that may help explain why certain Alzheimer’s disease patients experience a more rapid decline in cognitive (thinking) abilities.
A certain amount of memory loss is normal as we age but some patients can experience memory loss that is greater than expected. These patients may be suffering from mild cognitive impairment (MCI). Patients with MCI can live independently, unlike patients with dementia; however, medical researchers are learning that MCI may be a warning sign of a more serious illness.
The results of a new study led by Dr. Dennis Selkoe, co-director of the Center for Neurologic Diseases at Brigham and Women’s Hospital, provides scientific reasons for why a mentally stimulating environment, which includes learning new activities, may reduce the risk of Alzheimer’s disease.
Finding better ways to detect and potentially treat Alzheimer’s disease in its early stages is key to improving the quality of life for those affected. Research led by Dr. Amariglio has found that the subtle changes that people observe in their own memory, called “subjective cognitive concerns,” may help physicians identify people at risk for Alzheimer’s disease.